Send to

Choose Destination
Clin Exp Rheumatol. 2003 Jan-Feb;21(1):83-6.

Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis.

Author information

Queen's University, Muskuloskeletal Education and Research Unit, Department of Rheumatology, Musgrave Park Hospital, Stockman's Lane, Belfast BT9 7JB, Northern Ireland, UK.



We aimed to determine the expression of the interleukin-10 receptor (IL10R) on circulating leukocytes in SLE and rheumatoid arthritis, and correlate this with plasma IL-10 levels and disease activity.


Peripheral blood was sampled from 20 SLE patients, 14 rheumatoid arthritis patients, and 14 healthy controls. IL-10R expression was determined by immunofluorescence labelling and flow cytometric analysis. Plasma IL-10 levels were measured by ELISA.


IL-10R was highly expressed on monocytes, and to a lesser degree on neutrophils in all 3 patient groups. Only a small percentage of lymphocytes expressed IL-10R in all three groups. There was no significant difference in IL-10R expression on the surface of monocytes, neutrophils or lymphocytes in any of the 3 groups. IL-10R expression did not correlate with plasma IL-10 levels or disease activity.


This study has shown no difference in surface IL-10R expression between SLE, rheumatoid arthritis and normal subjects. Deficient or excessive circulating leukocyte surface IL-10R expression therefore does not seem to play a role in the pathogenesis of SLE or rheumatoid arthritis. Functional IL-10R studies would be of interest.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center